Dr. Omics Labs Selected for the Pfizer INDovation Program to Advance Healthcare Innovation in India
Dr. Omics Labs has been selected for Pfizer INDovation, Pfizer India's flagship healthcare innovation program run with FITT IIT Delhi, Social Alpha and Government of India partners
About this Achievement
Dr. Omics Labs has been selected for the Pfizer INDovation Program [Edition, e.g. IP Support Edition 2025–26], Pfizer India's flagship initiative for healthcare startups with high potential. Pfizer runs the program as part of its Corporate Social Responsibility work, with the Foundation for Innovation and Technology Transfer (FITT) at IIT Delhi, Social Alpha and Government of India partners. Startups are selected through a competitive, multi-stage evaluation. Being selected recognises Dr. Omics Labs' work in bioinformatics-driven genomic analysis for healthcare and its potential to improve healthcare in India.
What is the Pfizer INDovation Program?
Pfizer INDovation is a healthcare innovation and incubation program from Pfizer India. It helps Indian startups take breakthrough healthcare ideas from the lab to the market. Selected startups receive support such as grants, expert mentorship, incubation, intellectual property (IP) guidance, clinical and regulatory advice, and access to investors and industry networks.
The program began in 2015 as the Pfizer–IIT Delhi Innovation and IP Program, run with FITT at IIT Delhi. In 2022 it was relaunched as Pfizer INDovation with partners including Atal Innovation Mission (NITI Aayog), AGNIi and Social Alpha. Later editions have involved the National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, the Department of Pharmaceuticals, and the Department for Promotion of Industry and Internal Trade (DPIIT) under the Startup India initiative. Across its editions, INDovation has supported more than 40 Indian healthtech startups.
How are startups selected for Pfizer INDovation?
Selection is highly competitive. Each edition receives applications from startups across India, and only a small number are chosen. Applicants are assessed on:
- Potential impact on public health
- Level of technological innovation
- Uniqueness of the value proposition
- Competitive differentiation
- Financial and operational scalability
- Clarity of the development roadmap
Clearing this evaluation shows that experienced experts from industry, academia and government have independently reviewed Dr. Omics Labs' innovation, team and plan, and backed them.
What was Dr. Omics Labs selected for?
Dr. Omics Labs was selected for Cardio Pharmacogenomics initiative. Through the program, Dr. Omics Labs will receive grant funding, IP consultation, commercialisation support, mentorship and investor access to speed up the development and real-world use of this work.
Why does this selection matter?
It is independent validation. Pfizer INDovation partners are among the most respected names in Indian healthcare and innovation, and selection follows a rigorous external review. It confirms that Dr. Omics Labs' science meets industry standards.
It strengthens the path from research to impact. Mentorship, IP and commercialisation support from Pfizer, FITT IIT Delhi and Social Alpha will help Dr. Omics Labs turn its research into healthcare solutions that can be used at scale.
It benefits our learners. The same research and innovation work feeds into our training programmes. Students at Dr. Omics Labs learn bioinformatics from a team that is actively building healthcare solutions recognised by industry leaders.
It supports India's healthcare innovation ecosystem. The selection places Dr. Omics Labs among a group of Indian startups working on affordable, scalable healthcare solutions that the country needs.
Dr. Omics Labs: Credentials at a Glance
| Area | Details |
|---|---|
| Founder | Dr. Deepshikha Satish, PhD (ICGEB), translational bioinformatician with 10+ international publications |
| Founder recognition | Woman Entrepreneur of the Year 2024 |
| Learners trained | 50,000+ |
| Research grants and funding | DST, AWS, Illumina, Pfizer–IIT Delhi |
| Skill development partnership | LSSSDC (Life Sciences Sector Skill Development Council), Government of India |
| Academic partnership | CHRIST (Deemed to be University), SRM Chennai |
| Services | NGS data analysis and computer-aided drug design (CADD) |
About Dr. Omics Labs
Dr. Omics Labs (Dr. Omics Research and Education Private Limited) is a genomics and bioinformatics research and education organisation based in Delhi. It was founded by Dr. Deepshikha Satish, PhD, who trained at the International Centre for Genetic Engineering and Biotechnology (ICGEB).
Dr. Omics Labs combines research with training. Its working genomics lab provides NGS data analysis and computer-aided drug design services to researchers and industry. The same team delivers hands-on bioinformatics education through the LSSSDC-certified Bioinformatics Analyst course, NEP 2020 internships, webinars and workshops.
Frequently Asked Questions
What is the Pfizer INDovation Program?
It is Pfizer India's flagship CSR program for healthcare startups. It offers grants, incubation, mentorship, IP support and investor access to innovations that can improve healthcare in India.
Who runs the Pfizer INDovation Program?
Pfizer India runs it with partners including FITT at IIT Delhi and Social Alpha, along with Government of India bodies such as Atal Innovation Mission (NITI Aayog) and DPIIT in different editions.
Which edition of Pfizer INDovation was Dr. Omics Labs selected for?
Dr. Omics Labs was selected for the [edition 2025-26}.
What was Dr. Omics Labs selected for?
Dr. Omics Labs was selected for [one-sentence description of the innovation].
How competitive is selection for Pfizer INDovation?
Very competitive. Applications come from startups across India and are judged on public health impact, technological innovation, uniqueness, scalability and the development roadmap. Only a small number are chosen in each edition.
What support does Dr. Omics Labs receive through the program?
Dr. Omics Labs receives grant funding, IP and commercialisation support, mentorship and investor access to accelerate its innovation.
How does this recognition benefit Dr. Omics Labs students?
Students learn from a team whose research is recognised by Pfizer and IIT Delhi's innovation ecosystem. This keeps the training grounded in real, industry-relevant healthcare problems.
Who founded Dr. Omics Labs?
Dr. Deepshikha Satish, PhD, a translational bioinformatician trained at ICGEB, with more than 10 international publications. She was named Woman Entrepreneur of the Year 2024.
Want to learn bioinformatics from an award-winning genomics team, or collaborate with us on research? Contact us at info@dromicslabs.com or +91 93108 70544, or explore our courses.
